EXOZ
Exozymes Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Exozymes Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No other changes.
No other changes.
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. The company was founded in 2014 and is headquartered in Monrovia, California.
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. The company was founded in 2014 and is headquartered in Monrovia, California.
Annual filing, covered
10-K parsed · Mar 30 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 30 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Largest filed tie
0
filed ties
—
Same SIC code · 6
Same SEC industry code: Amgen Inc, Gilead Sciences, Inc., Biogen Inc. and 3 more; no measured co-movers for Exozymes Inc..
Same SIC code · 6
Same SEC industry code: Amgen Inc, Gilead Sciences, Inc., Biogen Inc. and 3 more; no measured co-movers for Exozymes Inc..
Exozymes Inc.
4.39
—
No thesis.
| Manager | Value | % base | |
|---|---|---|---|
| Vanguardindex-like | $463,524 | 44.23% | +147.79% |
| Davidson Kahn | $210,750 | 20.11% | new |
| Geodeindex-like | $197,312 | 18.83% | +6.92% |
| BlackRockindex-like | $81,012 | 7.73% | +41.39% |
| Vanguard Fiduciary Trustindex-like | $79,461 | 7.58% | 0.00% |
| Manager | Value | % base | |
|---|---|---|---|
| Vanguardindex-like | $463,524 | 44.23% | +147.79% |
| Davidson Kahn | $210,750 | 20.11% | new |
| Geodeindex-like | $197,312 | 18.83% | +6.92% |
| BlackRockindex-like | $81,012 | 7.73% | +41.39% |
| Vanguard Fiduciary Trustindex-like | $79,461 | 7.58% | 0.00% |
+57.77%
shares held · 7 largest managers
Expected move
No implied move.